Forensic Science, Medicine, and Pathology

, Volume 13, Issue 2, pp 217–225 | Cite as

Sudden death due to catecholaminergic polymorphic ventricular tachycardia following negative stress-test outcome: genetics and clinical implications

  • Cristian D’Ovidio
  • Aldo Carnevale
  • Vincenzo M. Grassi
  • Enrica Rosato
  • Bernat Del Olmo
  • Monica Coll
  • Oscar Campuzano
  • Anna Iglesias
  • Ramon Brugada
  • Antonio OlivaEmail author
Case Report


This paper discusses the case of a young boy who died suddenly during a football match. The victim’s personal and family medical histories were negative for cardiac events. He had undergone a cardiological investigation some months before his death, enabling him to participate in competitive sports. Only post-mortem molecular analysis allowed for a clearer determination of the most plausible cause of death, which was identified as inherited arrhythmogenic heart disease, known as catecholaminergic polymorphic ventricular tachycardia. It was possible to detect a novel, previously undescribed, variant in the RYR2 gene. This case report highlights the importance of a meaningful forensic multidisciplinary investigation in such cases, and also discusses possible medical malpractice claims.


Catecholaminergic polymorphic ventricular tachycardia Rare variant Sudden cardiac death Stress electrocardiogram Provocation test 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Human and animal studies

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Oral informed consent was obtained from the family of the victim.

Declaration of interest

The Authors declare no sources of funding, direct or indirect, and any connection of any of the researchers with the tobacco, alcohol, pharmaceutical or gaming industries or anybody substantially funded by one of these organizations. The Authors declare also that there are no contractual constraints on publishing imposed by any funder.


  1. 1.
    Bagnall RD, Weintraub RG, Ingles J, Duflou J, Yeates L, Lam L, et al. A prospective study of sudden cardiac death among children and young adults. N Engl J Med. 2016;374:2441–52.CrossRefGoogle Scholar
  2. 2.
    Skinner JR, Crawford J, Smith W, Aitken A, Heaven D, Evans CA, et al. Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds. Heart Rhythm. 2011;8:412–9.CrossRefGoogle Scholar
  3. 3.
    Ackerman MJ. State of postmortem genetic testing known as the cardiac channel molecular autopsy in the forensic evaluation of unexplained sudden cardiac death in the young. Pacing Clin Electrophysiol. 2009;32(Suppl 2):S86–9.CrossRefGoogle Scholar
  4. 4.
    Campuzano O, Allegue C, Partemi S, Iglesias A, Oliva A, Brugada R. Negative autopsy and sudden cardiac death. Int J Legal Med. 2014;128:599–606.CrossRefGoogle Scholar
  5. 5.
    Stattin EL, Westin IM, Cederquist K, Jonasson J, Jonsson BA, Morner S, et al. Genetic screening in sudden cardiac death in the young can save future lives. Int J Legal Med. 2016;130:59–66.CrossRefGoogle Scholar
  6. 6.
    Partemi S, Cestele S, Pezzella M, Campuzano O, Paravidino R, Pascali VL, et al. Loss-of-function KCNH2 mutation in a family with long QT syndrome, epilepsy, and sudden death. Epilepsia. 2013;54:e112–6.CrossRefGoogle Scholar
  7. 7.
    Campuzano O, Sanchez-Molero O, Allegue C, Coll M, Mademont-Soler I, Selga E, et al. Post-mortem genetic analysis in juvenile cases of sudden cardiac death. Forensic Sci Int. 2014;245:30–7.CrossRefGoogle Scholar
  8. 8.
    Oliva A, Grassi VM, Campuzano O, Brion M, Arena V, Partemi S, et al. Medico-legal perspectives on sudden cardiac death in young athletes. Int J Legal Med. 2017;131(2):393–409.CrossRefGoogle Scholar
  9. 9.
    Behr E, Wood DA, Wright M, Syrris P, Sheppard MN, Casey A, et al. Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet. 2003;362:1457–9.CrossRefGoogle Scholar
  10. 10.
    Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation. 2005;112:207–13.CrossRefGoogle Scholar
  11. 11.
    Kauferstein S, Kiehne N, Jenewein T, Biel S, Kopp M, Konig R, et al. Genetic analysis of sudden unexplained death: a multidisciplinary approach. Forensic Sci Int. 2013;229:122–7.CrossRefGoogle Scholar
  12. 12.
    Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128:873–934.CrossRefGoogle Scholar
  13. 13.
    Skinner JR, Duflou JA, Semsarian C. Reducing sudden death in young people in Australia and New Zealand: the TRAGADY initiative. Med J Aust. 2008;189:539–40.PubMedGoogle Scholar
  14. 14.
    Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European heart rhythm association (EHRA). Europace. 2011;13:1077–109.CrossRefGoogle Scholar
  15. 15.
    Marco-Sola S, Sammeth M, Guigo R, Ribeca P. The GEM mapper: fast, accurate and versatile alignment by filtration. Nat Methods. 2012;9:1185–8.CrossRefGoogle Scholar
  16. 16.
    Exome Variant Server NGESPE. Seattle, WA. Available at Accessed 1 Apr 2017.
  17. 17.
    Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56–65.CrossRefGoogle Scholar
  18. 18.
    Yates A, Akanni W, Amode MR, Barrell D, Billis K, Carvalho-Silva D, et al. Ensembl 2016. Nucleic Acids Res. 2016;44:D710–6.CrossRefGoogle Scholar
  19. 19.
    Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human Gene mutation database (HGMD): 2003 update. Hum Mutat. 2003;21:577–81.CrossRefGoogle Scholar
  20. 20.
    Exome Aggregation Consortium (ExAC) Cambridge, MA, USA.
  21. 21.
    Exome Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, WA, USA.
  22. 22.
    Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013;Chapter 7:Unit7.20.Google Scholar
  23. 23.
    Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361–2.CrossRefGoogle Scholar
  24. 24.
    Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One. 2012;7:e46688.CrossRefGoogle Scholar
  25. 25.
    Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–81.CrossRefGoogle Scholar
  26. 26.
    Hofer F, Fellmann F, Schlapfer J, Michaud K. Sudden cardiac death in the young (5-39 years) in the canton of Vaud, Switzerland. BMC Cardiovasc Disord. 2014;14:140.CrossRefGoogle Scholar
  27. 27.
    Germann CA, Perron AD. Sudden cardiac death in athletes: a guide for emergency physicians. Am J Emerg Med. 2005;23:504–9.CrossRefGoogle Scholar
  28. 28.
    Oliva A, Brugada R, D'Aloja E, Boschi I, Partemi S, Brugada J, et al. State of the art in forensic investigation of sudden cardiac death. Am J Forensic Med Pathol. 2011;32:1–16.CrossRefGoogle Scholar
  29. 29.
    Wilhelm M, Bolliger SA, Bartsch C, Fokstuen S, Grani C, Martos V, et al. Sudden cardiac death in forensic medicine - Swiss recommendations for a multidisciplinary approach. Swiss Med Wkly. 2015;145:w14129.PubMedGoogle Scholar
  30. 30.
    Michaud K, Mangin P, Elger BS. Genetic analysis of sudden cardiac death victims: a survey of current forensic autopsy practices. Int J Legal Med. 2011;125:359–66.CrossRefGoogle Scholar
  31. 31.
    Anderson JH, Tester DJ, Will ML, Ackerman MJ. Whole-exome molecular autopsy after exertion-related sudden unexplained death in the young. Circ Cardiovasc Genet. 2016;9:259–65.CrossRefGoogle Scholar
  32. 32.
    Chockalingam P, Mizusawa Y, Wilde AA. Channelopathies - emerging trends in the management of inherited arrhythmias. Indian Pacing Electrophysiol J. 2015;15:43–54.CrossRefGoogle Scholar
  33. 33.
    Grani C, Chappex N, Fracasso T, Vital C, Kellerhals C, Schmied C, et al. Sports-related sudden cardiac death in Switzerland classified by static and dynamic components of exercise. Eur J Prev Cardiol. 2016;23:1228–36.CrossRefGoogle Scholar
  34. 34.
    Chappex N, Schlaepfer J, Fellmann F, Bhuiyan ZA, Wilhelm M, Michaud K. Sudden cardiac death among general population and sport related population in forensic experience. J Forensic Legal Med. 2015;35:62–8.CrossRefGoogle Scholar
  35. 35.
    Sarquella-Brugada G, Campuzano O, Iglesias A, Sanchez-Malagon J, Guerra-Balic M, Brugada J, et al. Genetics of sudden cardiac death in children and young athletes. Cardiol Young. 2013;23:159–73.CrossRefGoogle Scholar
  36. 36.
    Haugaa KH, Leren IS, Berge KE, Bathen J, Loennechen JP, Anfinsen OG, et al. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening. Europace. 2010;12:417–23.CrossRefGoogle Scholar
  37. 37.
    Pflaumer A, Davis AM. Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia. Heart Lung Circ. 2012;21:96–100.CrossRefGoogle Scholar
  38. 38.
    van der Werf C, Zwinderman AH, Wilde AA. Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments. Europace. 2012;14:175–83.CrossRefGoogle Scholar
  39. 39.
    Domingo D, Lopez-Vilella R, Arnau MA, Cano O, Fernandez-Pons E, Zorio E. A new mutation in the ryanodine receptor 2 gene (RYR2 C2277R) as a cause catecholaminergic polymorphic ventricular tachycardia. Rev Esp Cardiol (Engl Ed). 2015;68:71–3.CrossRefGoogle Scholar
  40. 40.
    Postma AV, Denjoy I, Kamblock J, Alders M, Lupoglazoff JM, Vaksmann G, et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet. 2005;42:863–70.CrossRefGoogle Scholar
  41. 41.
    Ohno S, Hasegawa K, Horie M. Gender differences in the inheritance mode of RYR2 mutations in catecholaminergic polymorphic ventricular tachycardia patients. PLoS One. 2015;10:e0131517.CrossRefGoogle Scholar
  42. 42.
    Nakajima T, Kaneko Y, Kurabayashi M. Unveiling specific triggers and precipitating factors for fatal cardiac events in inherited arrhythmia syndromes. Circ J. 2015;79:1185–92.CrossRefGoogle Scholar
  43. 43.
    Leren IS, Haugaa KH, Edvardsen T, Anfinsen OG, Kongsgard E, Berge KE, et al. Catecholaminergic polymorphic ventricular tachycardia. Tidsskr Nor Laegeforen. 2010;130:139–42.CrossRefGoogle Scholar
  44. 44.
    Elger B, Michaud K, Mangin P. When information can save lives: the duty to warn relatives about sudden cardiac death and environmental risks. Hast Cent Rep. 2010;40:39–45.CrossRefGoogle Scholar
  45. 45.
    Napolitano C, Priori SG, Bloise R. Catecholaminergic polymorphic ventricular tachycardia. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, LJH B, et al., editors. GeneReviews(R). Seattle: University of Washington, Seattle University of Washington, Seattle ; 2004.GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reservedGoogle Scholar
  46. 46.
    Hayashi M, Denjoy I, Hayashi M, Extramiana F, Maltret A, Roux-Buisson N, et al. The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands. Europace. 2012;14:1344–51.CrossRefGoogle Scholar
  47. 47.
    Tan JH, Scheinman MM. Exercise-induced polymorphic ventricular tachycardia in adults without structural heart disease. Am J Cardiol. 2008;101:1142–6.CrossRefGoogle Scholar
  48. 48.
    Mohamed U, Napolitano C, Priori SG. Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol. 2007;18:791–7.CrossRefGoogle Scholar
  49. 49.
    Brunetti ND, De Gennaro L, Gaglione A, Di Biase M. An unusual catecholaminergic polymorphic ventricular tachycardia not inducible at stress test. Int J Cardiol. 2011;153:e54–5.CrossRefGoogle Scholar
  50. 50.
    Bauce B, Rampazzo A, Basso C, Bagattin A, Daliento L, Tiso N, et al. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol. 2002;40:341–9.CrossRefGoogle Scholar
  51. 51.
    Kozlovski J, Ingles J, Connell V, Hunt L, McGaughran J, Turner C, et al. Delay to diagnosis amongst patients with catecholaminergic polymorphic ventricular tachycardia. Int J Cardiol. 2014;176:1402–4.CrossRefGoogle Scholar
  52. 52.
    Sweeting J, Semsarian C. Sudden cardiac death in athletes: still much to learn. Cardiol Clin. 2016;34:531–41.CrossRefGoogle Scholar
  53. 53.
    Marjamaa A, Laitinen-Forsblom P, Wronska A, Toivonen L, Kontula K, Swan H. Ryanodine receptor (RyR2) mutations in sudden cardiac death: studies in extended pedigrees and phenotypic characterization in vitro. Int J Cardiol. 2011;147:246–52.CrossRefGoogle Scholar
  54. 54.
    Cheung JW, Meli AC, Xie W, Mittal S, Reiken S, Wronska A, et al. Short-coupled polymorphic ventricular tachycardia at rest linked to a novel ryanodine receptor (RyR2) mutation: leaky RyR2 channels under non-stress conditions. Int J Cardiol. 2015;180:228–36.CrossRefGoogle Scholar
  55. 55.
    Sanchez O, Campuzano O, Fernandez-Falgueras A, Sarquella-Brugada G, Cesar S, Mademont I, et al. Natural and undetermined sudden death: value of post-mortem genetic investigation. PLoS One. 2016;11:e0167358.CrossRefGoogle Scholar
  56. 56.
    Semsarian C, Ingles J. Molecular autopsy in victims of inherited arrhythmias. J Arrhythm. 2016;32:359–65.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Cristian D’Ovidio
    • 1
  • Aldo Carnevale
    • 1
  • Vincenzo M. Grassi
    • 2
  • Enrica Rosato
    • 1
  • Bernat Del Olmo
    • 3
  • Monica Coll
    • 3
  • Oscar Campuzano
    • 3
  • Anna Iglesias
    • 3
  • Ramon Brugada
    • 3
  • Antonio Oliva
    • 2
    Email author
  1. 1.Section of Legal Medicine, Department of Medicine and Aging Sciences‘G. d’Annunzio’ University of Chieti-PescaraChietiItaly
  2. 2.Institute of Public Health, Legal Medicine SectionCatholic University, School of MedicineRomeItaly
  3. 3.Cardiovascular Genetics CentreUniversity of Girona-IDIBGIGironaSpain

Personalised recommendations